Penumbra, Inc.'s PEN is well poised for growth in the coming quarters. It is backed by consistent revenue growth momentum, courtesy of extraordinary patient outcomes with Lightning Flash, Lightning ...
Penumbra, Inc.'s PEN consistent revenue growth momentum is driven by the extraordinary patient outcomes with Lightning Flash, Lightning Bolt 7 and RED 72 with SENDit technology. The company’s vascular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results